The Regis Healthcare Ltd (ASX: REG) share price is in focus today after the company announced CEO and managing director Dr Linda Mellors will step down following six years at the helm.
What did Regis Healthcare report?
- Dr Linda Mellors has resigned as CEO and MD of Regis Healthcare after more than six years in the role.
- She will remain with the company during a six-month notice period to support a smooth transition.
- Regis has commenced an executive search to appoint a new CEO.
- Regis remains in a strong financial and operating position, according to the board.
- The company has recently navigated significant reforms, including the new Aged Care Act.
What else do investors need to know?
Dr Mellors’ departure comes after a period marked by sector reforms, the Royal Commission into Aged Care, and the COVID-19 pandemic. During her tenure, Regis invested heavily to enhance service quality and strengthen its executive team. The board has highlighted these achievements and reassured investors of Regis’ continued strong position.
The succession process is underway, with Dr Mellors set to remain active until a replacement is found. Regis’ board has underlined its commitment to strong governance and ongoing growth through this transition.
What did Regis Healthcare management say?
Regis chairman Graham Hodges said:
On behalf of the Board, I want to thank Linda for her outstanding leadership and commitment to Regis and the aged care sector more broadly. During her tenure, Linda has guided the company through a period of significant transformation and growth, including through the Royal Commission into Aged Care, the COVID pandemic and the more recent reforms associated with the new Aged Care Act. Her leadership of Regis has delivered significant growth in the business together with important investments in people, processes, and systems to maintain our focus on high quality care. Linda leaves the business in a strong financial and operating position and with a capable and experienced executive team. We wish her every success in the next chapter of her career.
What’s next for Regis Healthcare?
Regis will commence an executive search for its next CEO, aiming for a seamless leadership transition. The company has stated it remains focused on delivering quality care and driving operational improvements as the aged care sector continues to evolve.
With a strong financial footing and an experienced leadership team, Regis says it is well-placed to keep investing in service quality and adjusting to future industry reforms.
Regis Healthcare share price snapshot
Over the past 12 months, Regis Healthcare shares have increased 16%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 5% over the same period.
The post Regis Healthcare CEO resignation: Leadership transition update appeared first on The Motley Fool Australia.
Should you invest $1,000 in Regis Healthcare Limited right now?
Before you buy Regis Healthcare Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Regis Healthcare Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 18 November 2025
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Lendlease unveils $400m TRX sale and FY26 capital recycling update
- Reece announces $85 million on-market buyback target
- Aurizon lodges new 10-year network access undertaking with QCA
- Stockland announces estimated 1H26 distribution
- Champion Iron launches $289m Rana Gruber takeover: what shareholders need to know
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.
Leave a Reply